Simplex Trading’s Eiger BioPharmaceuticals EIGR Stock Holding History
Bought
Maintained
Sold
Other funds holding EIGR
6CM
Simplex Trading's EIGR Position: Q1 2024 in Review
Simplex Trading sold out of Eiger BioPharmaceuticals (EIGR) in Q1 2024, closing a stake of 437 shares — an estimated $2K sold.
Simplex Trading first reported a position in EIGR in Q1 2015 and held it in 13 quarters. The position peaked at $532K in Q1 2022. 24 funds tracked by Wall St. Rank hold EIGR as of Q1 2024.
- Simplex Trading reported no remaining Eiger BioPharmaceuticals position as of Q1 2024 after selling out during the quarter.
- Simplex Trading sold 437 Eiger BioPharmaceuticals shares in Q1 2024, an estimated $2K.
- Simplex Trading first reported a position in Eiger BioPharmaceuticals in Q1 2015 and held it in 13 quarters.
- Simplex Trading's Eiger BioPharmaceuticals position peaked at $532K in Q1 2022.
- 24 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals as of Q1 2024.
Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.